Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Harris, E Nigel ^a   Pierangeli, S S ^a   Gharavi, A E ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ANTIGEN; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; POLYSTYRENE;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031731413     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700232     Document Type: Conference Paper

References (47)

1. Harris EN. Syndrome of the Black Swan. BR J Rheumatol 1986; 26: 324-326.
2. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985, 11: 591-601.
3. Asherson RA. A 'primary'antiphosphohpid syndrome. J Rheumatol 1988; 15: 1742-1746.
4. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
5. Alarcon-Segovia D et al Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus Senim Arthritis Rheum 1992; 21. 275-286
6. Pictte JC, Wechsler B, Frances C, Godeau P. Systemic lupus crythematosus and the antiphospholipid syndrome reflections about relevance of ARA criteria. J Rheumatol 1992, 19: 1835-1837.
7. Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 3-9
8. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome Annu Rev Med 1995, 47: 533-553
9. Hughes GRV. The antiphospholipid syndrome. Lupus 1996; 5: 345-346
10. Gharavi AE, Wilson WA. The syndrome of thrombosis, thrombocytopenia and recurrent spontaneous abortions associated with antiphospholipid antibodies' Hughes syndrome. Lupus 1996, 5: 343-344.
11. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemoat 1995; 74: 329-337.
12. Piette JC 1996 diagnostic and classification criteria for the antiphospholipid/cofactor syndrome: a 'mission impossible'. Lupus 1996; 5 354-363.
13. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992, 19. 508-512
14. 2glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
15. Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 1990; 335. 1544-1547
16. 2glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994, 179: 457-462
17. 2glycoprotein 1 in the absence of phospholipid: importance of antigen density and bivalent binding. J Immunol 1995; 154: 954-960.
18. 2glycoprotein 1 antibodies, a marker of antiphospholipid syndrome? Lupus 1995: 4: 122-130.
19. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb Haemost 1991; 66: 629-632.
20. Rao LVM, Hoang AD, Rapaport SI Differences in interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin Thromb Haemost 1995, 73. 668-674.
21. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism? Blood 1993, 81: 2618-2625.
22. Krnic-Barrie S et al A retrospective review of 61 patients with antiphospholipid syndrome analysis of factors influencing recurrent thrombosis Arch Intern Med 1997; 157. 2101-2108
23. Khamashta A et al. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med 1995; 332: 993-997.
24. Derksen RHWM, De Groot PHG. Later I, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment Ann Rheum Dis 1993, 52; 689-692.
25. Branch DW et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience Obstet Gynecol 1992, 80 614-620.
26. Cowchock FS et al. Repeated fetal losses associated with antiphospholipid antibodies a collaborative randomized trial comparing prednisone to low-dose aspirin treatment. Am J Obstet Gynecol 1992; 166 1318-1322.
27. Spinnato JA, Clark AL, Picarangeh SS, Harris EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gyencol 1995, 172: 690-694.
28. Levine SR, Welch KMA. The spectrum of neurologic diseases associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies Arch Neural 1987, 44: 876-883
29. Merkel PA. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996; 101: 576-583
30. Harris EN et al Thrombosis, recurrent fetal loss, and thrombocytopenia Predictive value of the anticardiolipm antibody test Arch Intern Med 1986; 146: 2153-2156
31. Loizou et al Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 1988, 168. 525-531.
32. Escalante A, Brey RL, Mitchell BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus Am J Med 1995; 98: 559-565
33. Harris EN et al. Evaluation of the antiphospholipid test report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68 215-222.
34. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) Group Am J Clin Pathol 1990; 94: 476-484
35. Triplett DA. Antiphospholipid-protein antibodies' laboratory detection and clinical relevance Thromb Res 1995; 78: 1-31.
36. Harris EN, Pierangeli SS. A more specific ELISA assay for the detection of antiphospholipid antibodies. Clin Immunol Newsl 1995: 15: 26-28.
37. Pierangeli SS, Stewart M, Silva LK, Harris EN. An antiphospholipid wet workshop 7th International Symposium on Antiphospholipid Antibodies. J Rheumatol 1998; 25: 156-160.
38. Merkel PA et al. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with a variety of connective tissue diseases. J Rheumatol 1990, (in press).
39. 2glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 89. 397-402.
40. 2glycoprotein I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4. 122-130
41. 2glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost 1996, 75: 717-720.
42. 2GP1 clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost 75 (5): 717-720.
43. 2glycoprotein I in systemic lupus erythematosus and primary antiphospholipid syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 1998; 25 (4): 667-674.
44. 2glycoprotein I, a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 1997, 109 (2): 304-309
45. Pierangeli SS, Goldsmith GH, Branch DW, Harris EN. Antiphospholipid antibody: functional specificity for inhibition of prothrombin activation by the prothrombinase complex Br J Haematol 1997; 97 768-774.
46. 2glycorprotein I and human immunglobulin G antiphospholipid antibodies. Circulation 1996; 94: 1746-1751.
47. Edwards M et al. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 1997, 96 (12): 4380-4384.